Literature DB >> 25037872

Molecular imaging: the emerging role of optical imaging in nuclear medicine.

Fijs W B van Leeuwen1, Marion de Jong.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25037872     DOI： 10.1007/s00259-014-2845-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  8 in total

Review 1.  Small animal SPECT and its place in the matrix of molecular imaging technologies.

Authors:  Steven R Meikle; Peter Kench; Michael Kassiou; Richard B Banati
Journal:  Phys Med Biol       Date:  2005-10-24       Impact factor: 3.609

Review 2.  In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease.

Authors:  Robert S Negrin; Christopher H Contag
Journal:  Nat Rev Immunol       Date:  2006-06       Impact factor: 53.106

Review 3.  Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence.

Authors:  Patrick T K Chin; Mick M Welling; Stefan C J Meskers; Renato A Valdes Olmos; Hans Tanke; Fijs W B van Leeuwen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-15       Impact factor: 9.236

4.  Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results.

Authors:  L M A Crane; G Themelis; H J G Arts; K T Buddingh; A H Brouwers; V Ntziachristos; G M van Dam; A G J van der Zee
Journal:  Gynecol Oncol       Date:  2010-11-06       Impact factor: 5.482

5.  A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye.

Authors:  Oscar R Brouwer; Nynke S van den Berg; Hanna M Mathéron; Henk G van der Poel; Bas W van Rhijn; Axel Bex; Harm van Tinteren; Renato A Valdés Olmos; Fijs W B van Leeuwen; Simon Horenblas
Journal:  Eur Urol       Date:  2013-11-26       Impact factor: 20.096

6.  Clinical Cerenkov luminescence imaging of (18)F-FDG.

Authors:  Daniel L J Thorek; Christopher C Riedl; Jan Grimm
Journal:  J Nucl Med       Date:  2013-09-27       Impact factor: 10.057

Review 7.  Imaging in the era of molecular oncology.

Authors:  Ralph Weissleder; Mikael J Pittet
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

Review 8.  Imaging agents for the chemokine receptor 4 (CXCR4).

Authors:  Joeri Kuil; Tessa Buckle; Fijs W B van Leeuwen
Journal:  Chem Soc Rev       Date:  2012-06-28       Impact factor: 54.564
  8 in total
  5 in total

Review 1.  Biomarkers in preclinical cancer imaging.

Authors:  Monique R Bernsen; Klazina Kooiman; Marcel Segbers; Fijs W B van Leeuwen; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-12       Impact factor: 9.236

2.  U-SPECT-BioFluo: an integrated radionuclide, bioluminescence, and fluorescence imaging platform.

Authors:  Matthias N van Oosterom; Rob Kreuger; Tessa Buckle; Wendy A Mahn; Anton Bunschoten; Lee Josephson; Fijs Wb van Leeuwen; Freek J Beekman
Journal:  EJNMMI Res       Date:  2014-10-11       Impact factor: 3.138

3.  Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding.

Authors:  Dominik Summer; Leo Grossrubatscher; Milos Petrik; Tereza Michalcikova; Zbynek Novy; Christine Rangger; Maximilian Klingler; Hubertus Haas; Piriya Kaeopookum; Elisabeth von Guggenberg; Roland Haubner; Clemens Decristoforo
Journal:  Bioconjug Chem       Date:  2017-05-10       Impact factor: 4.774

Review 4.  Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives.

Authors:  Manja Kubeil; Irma Ivette Santana Martínez; Michael Bachmann; Klaus Kopka; Kellie L Tuck; Holger Stephan
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-31

Review 5.  Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX.

Authors:  Joseph Lau; Kuo-Shyan Lin; François Bénard
Journal:  Theranostics       Date:  2017-09-26       Impact factor: 11.556
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.